Persistent SARS-CoV-2 infection in immunocompromised patients facilitates rapid viral evolution: Retrospective cohort study and literature review.

Hettle, David; Hutchings, Stephanie; Muir, Peter; Moran, Ed

Hettle, David; Hutchings, Stephanie; Muir, Peter; Moran, Ed.

Afiliación

Hettle D; Department of Infection Sciences, Southmead Hospital, Bristol BS10 5NB, United Kingdom.
Hutchings S; Department of Infection Sciences, Southmead Hospital, Bristol BS10 5NB, United Kingdom.
Muir P; United Kingdom Health Security Agency (UKHSA) South-West Regional Laboratory, Southmead Hospital, Bristol BS10 5NB, United Kingdom.
Moran E; Department of Infection Sciences, Southmead Hospital, Bristol BS10 5NB, United Kingdom.

Clin Infect Pract ; 16: 100210, 2022 Nov.

Article en En | MEDLINE | ID: mdl-36405361

Palabras clave

Casirivimab/Imdevimab; Haematological malignancy; Hypogammaglobulinaemia; Immunocompromised; Monoclonal antibody; Persistent SARS-CoV-2 infection; Persistent infection; SARS-CoV-2; Variant of concern; Viral evolution

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Clin Infect Pract Año: 2022 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google